In recognition of World Asthma Day 2024, Mumbai-based Alkem Laboratories has announced 600 to 700 camps across India, collaborating with nearly 100 hospitals in tier-1 and tier-2 cities under its "Reliever Free India" initiative.

This nationwide initiative was launched in 2023 with an aim to revolutionise asthma management by advocating for a shift in focus from reliance on reliever medications to the importance of controller medications. Reliever medications provide quick relief during asthma symptoms by opening up the airways. Controller medications are taken regularly to prevent asthma symptoms and reduce inflammation in the airways. After a successful first year, Alkem is intensifying the campaign in its second year.

Asthma affects a staggering 262 million people globally, causing recurrent episodes of wheezing, breathlessness, chest tightness, and coughing. Despite advancements in medical treatment, asthma remains a significant challenge for patients and healthcare providers alike. Alkem recognizes the critical role that education plays in empowering individuals to effectively manage their asthma and lead fulfilling lives.

Through this campaign, Alkem Laboratories seeks to educate patients, healthcare professionals, and the general public about the benefits of controller medications in preventing asthma symptoms and reducing the need for rescue medication.